Skip to content
Triangle logo TriangleGet started
← Full study record

NCT00282087 · OUTCOME

Correlation Between Uterine Serosal Involvement and Tumor Response to Treatment (PFS)

Adjuvant Chemotherapy for High Risk Uterine Leiomyosarcoma · Source last updated 2014-12-01

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

Measure
NUMBER
Unit
participants
Interval / dispersion
Not reported
Time frame
2 years

What was measured

AJCC Stage I: No serosal involvement AJCC Stage II: No serosal involement AJCC Stage III: Serosal only

Groups in this outcome

Women Treated With Adjuvant Regimen for High Risk Uterine LMS

Not reported

Group identifiers and denominators belong to this outcome only. They may differ in another outcome or in safety reporting.

Analysis denominator · Participants

GroupSource count
Women Treated With Adjuvant Regimen for High Risk Uterine LMS47

Reported measurements

AJCC Stage I
Values in participants · Interval/dispersion: Not reported
GroupValueSpreadLowerUpperComment
Women Treated With Adjuvant Regimen for High Risk Uterine LMS0Not reportedNot reportedNot reportedNot reported
AJCC Stage II
Values in participants · Interval/dispersion: Not reported
GroupValueSpreadLowerUpperComment
Women Treated With Adjuvant Regimen for High Risk Uterine LMS6Not reportedNot reportedNot reportedNot reported
AJCC Stage III
Values in participants · Interval/dispersion: Not reported
GroupValueSpreadLowerUpperComment
Women Treated With Adjuvant Regimen for High Risk Uterine LMS41Not reportedNot reportedNot reportedNot reported

Source statistical analyses

Group order, estimate direction, methods and comments are retained. No treatment ranking is inferred.

  1. ci Num Sides
    TWO_SIDED
    group Description
    Uterine serosal involvement correlation with progression-free survival for patients on study treatment.
    group Ids
    1. OG000
    non Inferiority Type
    SUPERIORITY_OR_OTHER
    param Type
    Hazard Ratio (HR)
    param Value
    0.101
    statistical Method
    Cox Proportional Hazards
    tested Non Inferiority
    false
Complete source fields
analyses
  1. ci Num Sides
    TWO_SIDED
    group Description
    Uterine serosal involvement correlation with progression-free survival for patients on study treatment.
    group Ids
    1. OG000
    non Inferiority Type
    SUPERIORITY_OR_OTHER
    param Type
    Hazard Ratio (HR)
    param Value
    0.101
    statistical Method
    Cox Proportional Hazards
    tested Non Inferiority
    false
classes
  1. categories
    1. measurements
      1. group Id
        OG000
        value
        0
    title
    AJCC Stage I
  2. categories
    1. measurements
      1. group Id
        OG000
        value
        6
    title
    AJCC Stage II
  3. categories
    1. measurements
      1. group Id
        OG000
        value
        41
    title
    AJCC Stage III
denoms
  1. counts
    1. group Id
      OG000
      value
      47
    units
    Participants
description
AJCC Stage I: No serosal involvement AJCC Stage II: No serosal involement AJCC Stage III: Serosal only
groups
  1. id
    OG000
    title
    Women Treated With Adjuvant Regimen for High Risk Uterine LMS
param Type
NUMBER
reporting Status
POSTED
time Frame
2 years
title
Correlation Between Uterine Serosal Involvement and Tumor Response to Treatment (PFS)
type
SECONDARY
unit Of Measure
participants

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice